Bifurcation analysis of a mathematical model of atopic dermatitis to determine patient-specific effects of treatments on dynamic phenotypes.

Atopic dermatitis (AD) is a common inflammatory skin disease, whose incidence is currently increasing worldwide. AD has a complex etiology, involving genetic, environmental, immunological, and epidermal factors, and its pathogenic mechanisms have not yet been fully elucidated. Identification of AD risk factors and systematic understanding of their interactions are required for exploring effective prevention and treatment strategies for AD. We recently developed a mathematical model for AD pathogenesis to clarify mechanisms underlying AD onset and progression. This model describes a dynamic interplay between skin barrier, immune regulation, and environmental stress, and reproduced four types of dynamic behaviour typically observed in AD patients in response to environmental triggers. Here, we analyse bifurcations of the model to identify mathematical conditions for the system to demonstrate transitions between different types of dynamic behaviour that reflect respective severity of AD symptoms. By mathematically modelling effects of topical application of antibiotics, emollients, corticosteroids, and their combinations with different application schedules and doses, bifurcation analysis allows us to mathematically evaluate effects of the treatments on improving AD symptoms in terms of the patients' dynamic behaviour. The mathematical method developed in this study can be used to explore and improve patient-specific personalised treatment strategies to control AD symptoms.

[1]  M. Ono,et al.  Skin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity , 2011, PloS one.

[2]  Stephan Weidinger,et al.  Atopic dermatitis , 2016, The Lancet.

[3]  C. Flohr,et al.  New insights into the epidemiology of childhood atopic dermatitis , 2014, Allergy.

[4]  Thomas Bieber,et al.  Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? , 2017, The Journal of allergy and clinical immunology.

[5]  Rajesh Balkrishnan,et al.  The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society , 2005, Pediatric dermatology.

[6]  T. Ueta,et al.  Bifurcation of switched nonlinear dynamical systems , 1999 .

[7]  H. Williams,et al.  Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory , 2017, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[8]  Alan Hastings,et al.  Early warning signals: the charted and uncharted territories , 2013, Theoretical Ecology.

[9]  J. Leyden,et al.  Staphylococcus aureus in the lesions of atopic dermatitis , 1974, The British journal of dermatology.

[10]  Urs Frey,et al.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control , 2008, The Lancet.

[11]  Jonathan R. Brestoff,et al.  Commensal microbiota modulate gene expression in the skin , 2018, Microbiome.

[12]  A. Muraro,et al.  The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology , 2017, The Journal of allergy and clinical immunology.

[13]  Kazuyuki Aihara,et al.  Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.

[14]  Mauricio Barahona,et al.  Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis , 2013, Interface Focus.

[15]  S. Carpenter,et al.  Early-warning signals for critical transitions , 2009, Nature.

[16]  Thomas B. Clarke,et al.  Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. , 2009, The Journal of clinical investigation.

[17]  K. Barnes,et al.  Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2007, The Journal of allergy and clinical immunology.

[18]  J. Koenderink Q… , 2014, Les noms officiels des communes de Wallonie, de Bruxelles-Capitale et de la communaute germanophone.

[19]  José Carlos Goulart de Siqueira,et al.  Differential Equations , 1919, Nature.

[20]  Gouhei Tanaka,et al.  Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer , 2008 .

[21]  R. Unger,et al.  Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT , 2014, Bone Marrow Transplantation.

[22]  Arshdeep Singh,et al.  Atopic dermatitis: an overview. , 2012, American family physician.

[23]  H. Williams,et al.  Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention , 2014, The Journal of allergy and clinical immunology.

[24]  Thomas Bieber,et al.  Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? , 2014, The Journal of allergy and clinical immunology.

[25]  Jian-ping Tang,et al.  Prevalence of Atopic Dermatitis in Chinese Children aged 1–7 ys , 2016, Scientific Reports.

[26]  Christopher S. McGinnis,et al.  Cell population structure prior to bifurcation predicts efficiency of directed differentiation in human induced pluripotent cells , 2017, Proceedings of the National Academy of Sciences.

[27]  Gouhei Tanaka,et al.  Effects of seasonal variation patterns on recurrent outbreaks in epidemic models. , 2013, Journal of theoretical biology.

[28]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. , 2014, Journal of the American Academy of Dermatology.

[29]  Uri Alon,et al.  Prediction of multidimensional drug dose responses based on measurements of drug pairs , 2016, Proceedings of the National Academy of Sciences.

[30]  B. Chiang,et al.  Role of Bacterial Pathogens in Atopic Dermatitis , 2007, Clinical reviews in allergy & immunology.

[31]  Hiroshi Kawakami,et al.  Bifurcation of periodic responses in forced dynamic nonlinear circuits: Computation of bifurcation values of the system parameters , 1984 .

[32]  Allyson L. Byrd,et al.  Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis , 2017, Science Translational Medicine.

[33]  Mariko Okada-Hatakeyama,et al.  Mathematical modeling of atopic dermatitis reveals “double‐switch” mechanisms underlying 4 common disease phenotypes , 2017, The Journal of allergy and clinical immunology.

[34]  D. Koenig,et al.  Immediate and extended effects of sodium lauryl sulphate exposure on stratum corneum natural moisturizing factor , 2014, International journal of cosmetic science.

[35]  Y. Kuznetsov Elements of Applied Bifurcation Theory , 2023, Applied Mathematical Sciences.

[36]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[37]  M. Hirsch,et al.  Differential Equations, Dynamical Systems, and an Introduction to Chaos , 2003 .

[38]  E. Nilsson,et al.  Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. , 1992, Journal of the American Academy of Dermatology.

[39]  Grant Lythe,et al.  How many dendritic cells are required to initiate a T-cell response? , 2012, Blood.

[40]  J. Colquitt,et al.  Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once‐daily vs. more frequent use , 2005, The British journal of dermatology.

[41]  C. Budd,et al.  Review of ”Piecewise-Smooth Dynamical Systems: Theory and Applications by M. di Bernardo, C. Budd, A. Champneys and P. 2008” , 2020 .

[42]  Andreas Radbruch,et al.  GATA-3 transcriptional imprinting in Th2 lymphocytes: A mathematical model , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Hywel C Williams,et al.  Clinical practice. Atopic dermatitis. , 2005, The New England journal of medicine.

[44]  M. Boguniewicz,et al.  Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines , 2017, The Journal of allergy and clinical immunology.

[45]  A. Taïeb,et al.  Biologics in atopic dermatitis , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[46]  H. Ogawa,et al.  Current insights into the role of human β‐defensins in atopic dermatitis , 2017, Clinical and experimental immunology.